MAPT and early-onset autosomal dominant Alzheimer disease: Florzolotau (18F) (florzolotau, APN-1607, PM-PBB3) has been shown to be a probe for tau fibrils in an animal model and patients with Alzheimer’s disease and those with non-Alzheimer’s disease tauopathies.